EUVIMEDOntdek EUVIMED
CrossrefInfokaart

CD34 + cell yield among healthy donors: Large‐scale model development and validation

Abdullah Alswied, David Daniel, Leonard N. Chen, Tariq Alqahtani, Kamille Aisha West‐Mitchell

Journal of Clinical Apheresis · 2024-06 · 39 (3)

DOI: 10.1002/jca.22135 ↗
SamenvattingBibliografische gegevens

Samenvatting

Abstract Background Successful engraftment in hematopoietic stem cell transplantation necessitates the collection of an adequate dose of CD34+ cells. Thus, the precise estimation of CD34+ cells harvested via apheresis is critical. Current CD34+ cell yield prediction models have limited reproducibility. This study aims to develop a more reliable and universally applicable model by utilizing a large dataset, enhancing yield predictions, optimizing the collection process, and improving clinical outcomes. Materials and Methods A secondary analysis was conducted using the Center for International Blood and Marrow Transplant Research database, involving data from over 17 000 healthy donors who underwent filgrastim‐mobilized hematopoietic progenitor cell apheresis. Linear regression, gradient boosting regressor, and logistic regression classification models were employed to predict CD34+ cell yield. Results Key predictors identified include pre‐apheresis CD34+ cell count, weight, age, sex, and blood volume processed. The linear regression model achieved a coefficient of determination ( R 2 ) value of 0.66 and a correlation coefficient ( r ) of 0.81. The gradient boosting regressor model demonstrated marginally improved results with an R 2 value of 0.67 and an r value of 0.82. The logistic regression classification model achieved a predictive accuracy of 96% at the 200 × 10 6 CD34+ cell count threshold. At thresholds of 400, 600, 800, and 1000 × 10 6 CD34+ cell count, the accuracies were 88%, 83%, 83%, and 88%, respectively. The model demonstrated a high area under the receiver operator curve scores ranging from 0.90 to 0.93. Conclusion This study introduces advanced predictive models for estimating CD34+ cell yield, with the logistic regression classification model demonstrating remarkable accuracy and practical utility.

Kennis die bij uw werk past.

Van een gratis start via persoonlijk literatuuronderzoek tot de volledige Research Suite.

Tarieven bekijken →

Zijn alle volledige uitgeversteksten inbegrepen?

Nee. Bibliografische records, abstracts en volledige teksten zijn verschillende inhoudstypen. Beschikbaarheid hangt af van bron, open access en bestaande licenties. Een EUVIMED-abonnement vervangt geen aanvullende uitgeversrechten.

Tarieven bekijken →